Detalhe da pesquisa
1.
Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies.
Am J Epidemiol;
2024 Mar 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38517025
2.
An open-source implementation of tree-based scan statistics.
Pharmacoepidemiol Drug Saf;
33(3): e5765, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38453354
3.
The FAIRification of research in real-world evidence: A practical introduction to reproducible analytic workflows using Git and R.
Pharmacoepidemiol Drug Saf;
33(1): e5740, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38173166
4.
Emulation of randomized trials of direct oral anticoagulants with claims data and implications for new Factor XI inhibitors.
Pharmacoepidemiol Drug Saf;
33(5): e5813, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38720425
5.
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease.
Ann Intern Med;
176(8): 1047-1056, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37549393
6.
Prospective validation of a dynamic prognostic model for identifying COVID-19 patients at high risk of rapid deterioration.
Pharmacoepidemiol Drug Saf;
32(5): 545-557, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36464785
7.
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
Pharmacoepidemiol Drug Saf;
32(1): 44-55, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36215113
8.
Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.
JAMA;
329(16): 1376-1385, 2023 04 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37097356
9.
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.
Value Health;
25(10): 1663-1672, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36241338
10.
Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting.
Pharmacoepidemiol Drug Saf;
31(11): 1140-1152, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35984046
11.
Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting.
Pharmacoepidemiol Drug Saf;
31(4): 411-423, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35092316
12.
Active Surveillance of the Safety of Medications Used During Pregnancy.
Am J Epidemiol;
190(6): 1159-1168, 2021 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33423046
13.
A General Propensity Score for Signal Identification Using Tree-Based Scan Statistics.
Am J Epidemiol;
190(7): 1424-1433, 2021 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33615330
14.
Screening Medications for Association with Progression to Wet Age-Related Macular Degeneration.
Ophthalmology;
128(2): 248-255, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32777229
15.
Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology.
Pharmacoepidemiol Drug Saf;
30(6): 671-684, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33715267
16.
Using the Case-Crossover Design to Assess Short-Term Risks of Bleeding and Arterial Thromboembolism After Switching Between Oral Anticoagulants in a Population-Based Cohort of Patients With Atrial Fibrillation.
Am J Epidemiol;
189(12): 1467-1477, 2020 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32639512
17.
Use of Time-Dependent Propensity Scores to Adjust Hazard Ratio Estimates in Cohort Studies with Differential Depletion of Susceptibles.
Epidemiology;
31(1): 82-89, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31569120
18.
Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes.
Diabetes Obes Metab;
22 Suppl 3: 45-59, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32250527
19.
Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example.
Value Health;
23(2): 217-226, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32113627
20.
Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Value Health;
23(9): 1128-1136, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32940229